-
1دورية أكاديمية
المؤلفون: Storci, Gianluca, Barbato, Francesco, Ricci, Francesca, Tazzari, Pier Luigi, De Matteis, Serena, Tomassini, Enrica, Dicataldo, Michele, Laprovitera, Noemi, Arpinati, Mario, Ursi, Margherita, Maffini, Enrico, Campanini, Elena, Dan, Elisa, Manfroi, Silvia, Santi, Spartaco, Ferracin, Manuela, Bonafe, Massimiliano, Bonifazi, Francesca
المصدر: Frontiers in Immunology; 1/13/2023, Vol. 13, p1-14, 14p
مصطلحات موضوعية: EXTRACELLULAR vesicles, GRAFT versus host disease, HEMATOPOIETIC stem cell transplantation, HLA histocompatibility antigens, T cells
-
2دورية أكاديمية
المؤلفون: La Manna, Gaetano, Ghinatti, Giulia, Tazzari, Pier Luigi, Alviano, Francesco, Ricci, Francesca, Capelli, Irene, Cuna, Vania, Todeschini, Paola, Brunocilla, Eugenio, Pagliaro, Pasqualepaolo, Bonsi, Laura, Stefoni, Sergio
المصدر: PLoS ONE; Feb2014, Vol. 9 Issue 2, p1-9, 9p
مصطلحات موضوعية: GELATINASES, LIPOCALIN-2, CELL populations, HLA histocompatibility antigens, BLOOD cells, BIOMARKERS, IMMUNOLOGICAL tolerance
-
3دورية أكاديمية
المؤلفون: Pistillo, Maria Pia1 pistillo@ermes.cba.unige.it, Tazzari, Pier Luigi1, Gaudiano, Carlo1, Cilla, Vito1, Kato, Tomohiro1, Matsui, Toshihiro1, Nishioka, Kasuki1, Capanni, Paolo1, Conte, Roberto1, Ferrara, Giovanni Battista1, Pistillo, M P2 (AUTHOR), Tazzari, P L (AUTHOR), Gaudiano, C (AUTHOR), Cilla, V (AUTHOR), Kato, T (AUTHOR), Matsui, T (AUTHOR), Nishioka, K (AUTHOR), Capanni, P (AUTHOR), Conte, R (AUTHOR), Ferrara, G B (AUTHOR)
المصدر: Transfusion. Apr01, Vol. 41 Issue 4, p462-469. 8p. 2 Charts, 13 Graphs.
مصطلحات موضوعية: *IMMUNOGLOBULINS, *T cells, *BLOOD
-
4دورية أكاديمية
المؤلفون: Martelli, Alberto M.1 alberto.martelli@gmail.com, Lonetti, Annalisa1, Buontempo, Francesca1, Ricci, Francesca2, Tazzari, Pier Luigi2, Evangelisti, Camilla3,4, Bressanin, Daniela1, Cappellini, Alessandra5, Orsini, Ester1, Chiarini, Francesca3,4
المصدر: Advances in Biological Regulation. Sep2014, Vol. 56, p6-21. 16p.
مصطلحات موضوعية: *LYMPHOBLASTIC leukemia treatment, *CELLULAR signal transduction, *T cells, *CANCER relapse, *DRUG resistance in cancer cells, *HEMATOPOIETIC stem cells